TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

LITERATURVERZEICHNIS
and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J.
Cell. Physiol. 159: 101-113.
RUBIN, L.L., HALL, D.E., PORTER, S., BARBU, K., CANNON, C., HORNER, H.C., JANATPOUR, M.,
LIAW, C.W., MANNING, K., MORALES, J., TANNER, L.I., TOMASELLI, K.J., BARD, F., 1991.
A cell culture model of the blood-brain barrier. J Cell Biol. 115: 1725-1735.
SAKAEDA, T., NAKAMURA, T., OKUMURA, K., 2003. Pharmacogenetics of MDR1 and ist impact on
the pharmacokinetics and pharmacodynamics of drugs. Pharmacogenomics 4: 397–410.
SANDER, J.W., 2003. The epidemiology of epilepsy revisited. Curr Opin Neurol. 16: 165-170.
SAWCHUK, R.J., ELMQUIST, W.F., 2000. Microdialysis in the study of drug transporters in the CNS.
Adv Drug Deliv Rev. 45: 295–307.
SCHERRMANN, J.M., 2005. Expression and function of multidrug resistance transporters at the
blood-brain barriers. Expert Opin Drug Metab Toxicol. 1: 233-46.
SCHIERA, G., BONO, E., RAFFA, M.P., GALLO, A., PITARRESI, G.L., DI LIEGRO, I., SAVETTIERI,
G., 2003. Synergistic effects of neurons and astrocytes on the differentiation of brain capillary
endothelial cells in culture. J Cell Mol Med. 7: 165-170.
SCHINKEL, A.H., 1999. P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Deliv. Rev.
6: 179-194.
SCHINKEL, A.H., JONKER, J.W., 2003. Mammalian drug efflux transporters of the ATP binding
cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55: 3-29.
SCHINKEL, A.H., SMIT, J.J.M., VAN TELLINGEN, O., BEIJNEN, J.H., WAGENAAR, E., VAN
DEEMTER, L., MOL, C.A.A.M., VAN DER VALK, M.A., ROBANUS-MAANDAG, E.C., TE
RIELE, H.P.J., BERNS, A.J.M., BORST, P., 1994. Disruption of the mouse mdr1a P-
glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to
drugs. Cell 77: 491-502.
SCHINKEL, A.H., WAGENAAR, E., VAN DEEMTER, L., MOL, C.A.A.M., BORST, P., 1995. Absence
of the mdrla P-Glycoprotein in Mice Affects Tissue Distribution and Pharmacokinetics of
Dexamethasone, Digoxin, and Cyclosporin A. J. Clin. Invest. 96: 1698-1705.
SCHINKEL, A.H., WAGENAAR, E., MOL, C.A.A.M., VAN DEEMTER, L., 1996. P-glycoprotein in the
blood-brain barrier of mice influences the brain penetration and pharmacological activity of
many drugs. J. Clin. Invest. 97: 2517-2524.
SCHMIDT, D., LÖSCHER, W., 2005. Drug resistance in epilepsy: putative neurobiologic and clinical
mechanisms. Epilepsia 46: 858-77.
SCHMIDT, D., LÖSCHER, W., 2009. New developments in antiepileptic drug resistance: an
integrative view. Epilepsy Curr. 9: 47-52.
SCHUETZ, E.G., BECK, W.T., SCHUETZ, J.D., 1996. Modulators and substrates of P-glycoprotein
and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma
cells. Mol. Pharmacol. 49: 311-318.
SCHWAB, M., EICHELBAUM, M., FROMM, M.F., 2003a. Genetic polymorphisms of the human MDR1
drug transporter. Annu Rev Pharmacol Toxicol. 43: 285-307.
199